Skip to main content

Peer Review reports

From: Safety and effectiveness of adalimumab in a clinical setting that reflects Canadian standard of care for the treatment of rheumatoid arthritis (RA): Results from the CanACT study

Original Submission
29 Jun 2011 Submitted Original manuscript
9 Sep 2011 Author responded Author comments - Boulos Haraoui
15 Jul 2011 Reviewed Reviewer Report - Bernhard Manger
24 Jul 2011 Reviewed Reviewer Report - Rudolf Puchner
Resubmission - Version 2
9 Sep 2011 Submitted Manuscript version 2
16 Sep 2011 Author responded Author comments - Boulos Haraoui
Resubmission - Version 3
16 Sep 2011 Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
16 Nov 2011 Author responded Author comments - Boulos Haraoui
Resubmission - Version 5
16 Nov 2011 Submitted Manuscript version 5
Publishing
17 Nov 2011 Editorially accepted
17 Nov 2011 Article published 10.1186/1471-2474-12-261

You can find further information about peer review here.

Back to article page